Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression

J Affect Disord. 2009 Jan;112(1-3):206-11. doi: 10.1016/j.jad.2008.04.027. Epub 2008 Jun 17.

Abstract

Background: Major depression (MDD) is characterized by altered emotion processing and deficits in cognitive control. In cognitive interference tasks, patients with MDD have shown excessive amygdala activity and under-recruitment of dorsolateral prefrontal cortex (DLPFC). The purpose of this study was to examine the effects of antidepressant treatment on anomalous neural activity in cognitive-control and emotion-processing circuitry.

Methods: Functional magnetic resonance imaging was conducted on depressed patients (n=23) (both before and after antidepressant treatment) compared with matched controls (n=18) while they performed a cognitive task involving attended and unattended fear-related stimuli.

Results: After eight weeks of SSRI antidepressant treatment, patients with depression showed significantly increased DLPFC activity to unattended fear-related stimuli and no longer differed from controls in either DLPFC or amygdala activity.

Conclusions: These results suggest that antidepressant treatment increases DLPFC under-activity during cognitive tasks that include emotional interference.

Limitations: The sample was fairly homogeneous and this may limit generalizability.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amygdala / drug effects
  • Amygdala / physiopathology
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use*
  • Attention / drug effects
  • Attention / physiology
  • Cognition / drug effects*
  • Cognition / physiology
  • Control Groups
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / physiopathology
  • Emotions / drug effects*
  • Emotions / physiology
  • Fear / psychology
  • Female
  • Functional Laterality / drug effects
  • Functional Laterality / physiology
  • Humans
  • Magnetic Resonance Imaging / statistics & numerical data
  • Male
  • Neural Pathways / drug effects
  • Neural Pathways / physiopathology
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / physiopathology*
  • Recruitment, Neurophysiological / drug effects
  • Recruitment, Neurophysiological / physiology
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Task Performance and Analysis
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Serotonin Uptake Inhibitors